How to appeal a Humana experimental or investigational denial

Why Humana denies experimental or investigational

Humana is among the top three Medicare Advantage carriers and also operates Tricare and a smaller commercial book. Medicare Advantage prior auth is the highest-volume denial category.

For experimental or investigational specifically: Carriers commonly deny coverage by labeling a treatment 'experimental' or 'investigational' — a designation that bypasses the usual medical-necessity analysis. These denials are appealable, and many reverse when peer-reviewed evidence, compendia listings, or clinical-trial data are presented.

The Humana appeal process

Appeal levels: Medicare Advantage federal 5-level ladder. Commercial: internal then external review.

Timing: Medicare Advantage: 60 days between each level. Commercial: 180 days from denial for internal, 60 days for external.

What we know about Humana: Humana cases benefit most from level-2 (Maximus) escalation. We don't stop at level 1.

Common Humana denial patterns for experimental or investigational

• Five-level Medicare appeal process. Humana Medicare Advantage denials enter the federal appeal ladder: plan reconsideration → IRE (Maximus) → ALJ → Medicare Appeals Council → federal court. About 41% reverse at level 1; reversal probability remains high through level 3.
• DME (durable medical equipment) denials. Humana DME denials often cite missing home-evaluation documentation. Re-filing with the home-evaluation packet attached is the most common reversal path.
• Skilled nursing and post-acute care. Humana has been the subject of CMS audits on early termination of skilled nursing coverage. Appeals citing CMS coverage manual standards have a documented success record.

The reversal pathway for experimental or investigational appeals

Successful experimental or investigational appeals against Humana typically require:

1. Procedural-rights anchor. Every Humana denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter must invoke these in the opening paragraph to lock the timeline and force criteria disclosure.
2. Criteria-disclosure demand. Humana (like all major insurers) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Federal law requires they disclose on request — and once they do, the criteria become the rebuttal map.
3. Treating-provider attestation. A letter from the treating physician explaining medical necessity in the specific terms the carrier's policy uses. This is the single strongest evidentiary element.
4. Peer-reviewed citations. At least two journal citations (NEJM, JAMA, Lancet, etc.) or specialty-society guidelines (NCCN, AASM, ACR Appropriateness Criteria) supporting the requested service for the patient's clinical profile.
5. Plan-language anchor. The specific policy section that controls the determination, quoted verbatim with policy section number.
6. Requested action. Clear, specific request for reversal — not a general "please reconsider."

What Apellica does for Humana experimental or investigational appeals

We file appeals against Humana specifically configured to its internal review process. Every appeal includes the criteria-disclosure demand, the procedural-rights anchor, treating-provider attestation language, and the specific peer-reviewed citations relevant to the denied service.

Cost: $0 upfront. We work on contingency for Humana appeals — if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Related Humana guides

• Humana surgery denials appeal guide
• Humana mri and imaging denials appeal guide
• Humana medication and prescription denials appeal guide
• Humana medicare denials appeal guide

Other carriers — experimental or investigational denials guides

• UnitedHealthcare experimental or investigational appeal guide
• Aetna (CVS Health) experimental or investigational appeal guide
• Cigna (Evernorth) experimental or investigational appeal guide
• Anthem / BlueCross BlueShield experimental or investigational appeal guide